Pathophysiology

Pathophysiology (or physiopathology) is a branch of study, at the intersection of pathology and physiology, concerning disordered physiological processes that cause, result from, or are otherwise associated with a disease or injury. Pathology is the medical discipline that describes conditions typically observed during a disease state, whereas physiology is the biological discipline that describes processes or mechanisms operating within an organism. Pathology describes the abnormal or undesired condition (symptoms of a disease), whereas pathophysiology seeks to explain the functional changes that are occurring within an individual due to a disease or pathologic state.[1]

## Contents

* 1 Etymology
* 2 History
* 2.1 Early Developments
* 2.2 Nineteenth century
* 2.2.1 Reductionism
* 2.2.2 Germ theory
* 2.2.3 Scientific medicine
* 2.3 Twentieth century
* 2.3.1 Biomedicine
* 2.3.2 Molecular paradigm
* 2.3.3 Disease mechanisms
* 3 Examples
* 3.1 Parkinson's disease
* 3.2 Heart failure
* 3.3 Multiple sclerosis
* 3.4 Hypertension
* 3.5 HIV/AIDS
* 3.6 Spider bites
* 3.7 Obesity
* 4 See also
* 5 References

## Etymology

The term pathophysiology comes from the Ancient Greek πάθος (pathos) and φυσιολογία (phisiologia).

## History

### Early Developments

The origins of pathophysiology as a distinct field date back to the late 18th century. The first known lectures on the subject were delivered by Professor August Friedrich Hecker [de; de] at the University of Erfurt in 1790, and in 1791, he published the first textbook on pathophysiology, Grundriss der Physiologia pathologica,[2] spanning 770 pages.[3] Hecker also established the first academic journal in the field, Magazin für die pathologische Anatomie und Physiologie, in 1796.[4] The French physician Jean François Fernel had earlier suggested in 1542 that a distinct branch of physiology should study the functions of diseased organisms, an idea further developed by Jean Varandal [de; de] in 1617, who first coined the term "pathologic physiology" in a medical text.[4]

### Nineteenth century

#### Reductionism

In Germany in the 1830s, Johannes Peter Müller led the establishment of physiology research as autonomous from medical research. In 1843, the Berlin Physical Society was founded in part to purge biology and medicine of vitalism, and in 1847, Hermann von Helmholtz, who joined the Society in 1845, published the paper "On the conservation of energy", highly influential in reducing physiology's research foundation to physical sciences. In the late 1850s, German anatomical pathologist Rudolf Virchow, a former student of Müller, directed focus to the cell, establishing cytology as the focus of physiological research. He also recognized pathophysiology as a distinct discipline, arguing that it should rely on clinical observation and experimentation rather than purely anatomical pathology.[4] Virchow’s influence extended to his student Julius Cohnheim, who pioneered experimental pathology and the usage of intravital microscopy, further advancing the study of pathophysiology.[4]

#### Germ theory

By 1863, motivated by Louis Pasteur's report on fermentation to butyric acid, fellow Frenchman Casimir Davaine identified a microorganism as the crucial causal agent of the cattle disease anthrax, but its routinely vanishing from blood left other scientists inferring it a mere byproduct of putrefaction.[5] In 1876, upon Ferdinand Cohn's report of a tiny spore stage of a bacterial species, the fellow German Robert Koch isolated Davaine's bacterides in pure culture—a pivotal step that would establish bacteriology as a distinct discipline—identified a spore stage, applied Jakob Henle's postulates, and confirmed Davaine's conclusion, a major feat for experimental pathology. Pasteur and colleagues followed up with ecological investigations confirming its role in the natural environment via spores in soil.

Also, as to sepsis, Davaine had injected rabbits with a highly diluted, tiny amount of putrid blood, duplicated disease, and used the term ferment of putrefaction, but it was unclear whether this referred as did Pasteur's term ferment to a microorganism or, as it did for many others, to a chemical.[6] In 1878, Koch published Aetiology of Traumatic Infective Diseases—unlike any previous work—in which, in 80 pages, Koch, as noted by a historian, "was able to show, in a manner practically conclusive, that a number of diseases, differing clinically, anatomically, and in aetiology, can be produced experimentally by the injection of putrid materials into animals."[6] Koch used bacteriology and the new staining methods with aniline dyes to identify particular microorganisms for each.[6] Germ theory of disease crystallized the concept of "cause" as presumably identifiable by scientific investigation.[7]

#### Scientific medicine

The American physician William Henry Welch trained in German pathology from 1876 to 1878, including under Julius Cohnheim, and opened America's first scientific laboratory—a pathology laboratory—at Bellevue Hospital in New York City in 1878.[8] Welch's course drew enrollment from students at other medical schools, which responded by opening their own pathology laboratories.[8] Once appointed by Daniel Coit Gilman, upon advice by John Shaw Billings, as founding dean of the medical school of the newly forming Johns Hopkins University that Gilman, as its first president, was planning, Welch traveled again to Germany for training in Koch's bacteriology in 1883.[8] Welch returned to America but moved to Baltimore, eager to overhaul American medicine, while blending Virchow's anatomical pathology, Cohnheim's experimental pathology, and Koch's bacteriology.[9] Hopkins medical school, led by the "Four Horsemen"—Welch, William Osler, Howard A. Kelly, and William Stewart Halsted—opened in 1893 as America's first medical school devoted to teaching German scientific medicine.[8]

### Twentieth century

#### Biomedicine

The first biomedical institutes, Pasteur Institute and Berlin Institute for Infectious Diseases, whose first directors were Louis Pasteur and Robert Koch, were founded in 1888 and 1891, respectively. America's first biomedical institute, The Rockefeller Institute for Medical Research, was founded in 1901 with Welch, nicknamed "dean of American medicine", as its scientific director, who appointed his former Hopkins student Simon Flexner as director of the pathology and bacteriology laboratories. Through the influence of World War I and World War II, the Rockefeller Institute emerged as the world's leading institution in biomedical research.[citation needed]

#### Molecular paradigm

The 1918 pandemic triggered a frenzied search for its cause, although most deaths were via lobar pneumonia, already attributed to pneumococcal invasion. In London, in 1928, a pathologist from the Ministry of Health named Fred Griffith documented pneumococcal transformation, showing how it could change from virulent to avirulent and shift between antigenic types—almost as if it was a different species—questioning pneumonia's straightforward causation.[10][11] The laboratory of Rockefeller Institute's Oswald T. Avery, an early pneumococcal expert, was so troubled by the report that they refused to attempt repetition.[12]

During Avery's summer vacation, Martin Henry Dawson, a British-Canadian who believed everything from England was correct by default, repeated Griffith's results and achieved transformation in vitro, making it a more precise investigation.[12] Having returned, Avery kept a photo of Griffith on his desk while his researchers followed the trail. In 1944, Avery, Colin Munro MacLeod, and Maclyn McCarty reported the transformation factor as DNA, widely doubted amid estimations that something must act with it.[13] At the time of Griffith's report, it was unrecognized that bacteria even had genes.[14]

The first genetics, Mendelian genetics, began in 1900, yet inheritance of Mendelian traits was localized to chromosomes by 1903, thus chromosomal genetics. Biochemistry emerged in the same decade.[15] In the 1940s, most scientists viewed the cell as a "sack of chemicals"—a membrane containing only loose molecules in Brownian motion—and the only especial cell structures as chromosomes, which bacteria lack as such.[15] Chromosomal DNA was presumed too simple, so genes were sought in chromosomal proteins. Yet in 1953, American biologist James Watson, British physicist Francis Crick, and British chemist Rosalind Franklin inferred DNA's molecular structure—a double helix—and conjectured it to spell a code. In the early 1960s, Crick helped crack the genetic code in DNA thus establishing molecular genetics.

In the late 1930s, the Rockefeller Foundation had spearheaded and funded the molecular biology research program—seeking a fundamental explanation of organisms and life—led largely by physicist Max Delbrück at Caltech and Vanderbilt University.[16] Yet the reality of organelles in cells was controversial amid unclear visualization with conventional light microscopy.[15] Around 1940, largely via cancer research at Rockefeller Institute, cell biology emerged as a new discipline filling the vast gap between cytology and biochemistry by applying new technology—ultracentrifuge and electron microscope—to identify and deconstruct cell structures, functions, and mechanisms.[15] The two new sciences interlaced, cell and molecular biology.[15]

Mindful of Griffith and Avery, Joshua Lederberg confirmed bacterial conjugation—reported decades earlier but controversial—and was awarded the 1958 Nobel Prize in Physiology or Medicine.[17] At Cold Spring Harbor Laboratory in Long Island, New York, Max Delbrück and Salvador Luria led the Phage Group—hosting Watson—discovering details of cell physiology by tracking changes to bacteria upon infection with their viruses, the process transduction. Lederberg led the opening of a genetics department at Stanford University's medical school, and facilitated greater communication between biologists and medical departments.[17]

#### Disease mechanisms

In the 1950s, research on rheumatic fever, a complication of streptococcal infections, revealed it was mediated by the host's own immune response, stirring investigation by pathologist Lewis Thomas that led to identification of enzymes released by the innate immune cells macrophages and that degrade host tissue.[18] In the late 1970s, as president of Memorial Sloan–Kettering Cancer Center, Thomas collaborated with Lederberg, soon to become president of Rockefeller University, to redirect the funding focus of the US National Institutes of Health toward basic research into the mechanisms operating during disease processes, which at the time medical scientists were all but wholly ignorant of, as biologists had scarcely taken interest in disease mechanisms.[19][20]

## Examples

### Parkinson's disease

The pathophysiology of Parkinson's disease (PD) involves the apoptosis, or programmed cell death, of dopaminergic neurons as a consequence of alterations in biological activity within the brain related to the disorder. Several mechanisms have been proposed to explain neuronal apoptosis in PD; however, not all of these mechanisms are fully understood. The five primary mechanisms believed to contribute to neuronal death in PD include protein aggregation within Lewy bodies, disruption of autophagy processes, alterations in cellular metabolism and mitochondrial function, neuroinflammation, and breakdown of the blood-brain barrier, resulting in vascular compromise.[21]

### Heart failure

The pathophysiology of heart failure involves a reduction in the efficiency of the cardiac muscle through damage or overloading. As such, it can be caused by a wide number of conditions, including myocardial infarction (in which ischemia of the heart muscle leads to its death), hypertension (which increases the force of contraction needed to pump blood), and amyloidosis (in which misfolded proteins are deposited in the heart muscle, causing it to stiffen). Over time, these increase the workload of the heart, leading to changes in the heart muscle itself.

### Multiple sclerosis

The pathophysiology of multiple sclerosis (MS) is that of an inflammatory demyelinating disease in which activated immune cells invade the central nervous system and cause neuroinflammation, neurodegeneration, and tissue damage. The underlying precipitators of MS are incompletely defined. Current research in neuropathology, neuroimmunology, neurobiology, neuroimaging, clinical neurology, and psychiatry provides support for the notion that MS is not a single disease but rather a spectrum.[22]

### Hypertension

The pathophysiology of hypertension is that of a chronic disease characterized by elevation of blood pressure. Hypertension can be classified by cause as either essential (also known as primary or idiopathic hypertension) or secondary. About 90–95% of hypertension is essential hypertension.[23][24][25][26]

### HIV/AIDS

The pathophysiology of HIV/AIDS involves the acquisition of HIV and the replication of the virus inside T helper cells, causing lysis. T helper cells are required for almost all adaptive immune system responses. There is typically an initial period of influenza-like illness following acquisition, and then a latent, asymptomatic phase. When the CD4 lymphocyte count falls below 200 cells/ml of blood, the HIV host has progressed to AIDS,[27] a condition characterized by deficiency in cell-mediated immunity and resultant increase in susceptibility to opportunistic infections and some cancers.

### Spider bites

The pathophysiology of spider bites involves the effect of injected venom. A spider envenomation occurs when a spider injects venom into the skin. Not all spider bites deliver venom—a dry bite—and the amount of venom injected can vary depending on the type of spider and the circumstances of the encounter. The mechanical injury from a spider bite is generally not a serious concern for humans.

### Obesity

The pathophysiology of obesity involves many developmental and maintenance processes.[28][29]

Research on obesity, as well as clinical obesity medicine, and had been almost unapproached until the leptin gene was discovered in 1994 in Jeffrey M. Friedman's laboratory.[30] The investigators hypothesized that leptin functions as a satiety factor. In the ob/ob mouse, mutations in the leptin gene led to the obese phenotype, suggesting potential for leptin-based therapies for human obesity. However, shortly after, Jose F. Caro's team failed to find any leptin gene mutations in humans with obesity. Instead, they observed increased leptin expression, indicating potential leptin resistance in human obesity.[31]

## See also

* Pathogenesis

## References

1. ↑ "Pathophysiology – Medical dictionary". TheFreeDictionary.com. Farlex, Inc. http://medical-dictionary.thefreedictionary.com/pathophysiology.
2. ↑ Hecker, August Friedrich (1791) (in de). Grundriss der Physiologia pathologica, oder die Lehre von dem Bau, von der Mischung, und von den Verrichtungen des menschlichen Körpers und seiner Theile im widernatürlichen Zustande. I. https://books.google.com/books?id=AM5vSxseazMC&pg=PR1.
3. ↑ Stoyanov, George S; Naskovska, Galina; Lyutfi, Emran; Kirneva, Rumiana; Bratoeva, Kameliya (2 April 2018). "In Search of the Ninth Discipline: The History of Pathophysiology, with an Emphasis on Pathophysiology in Varna, Bulgaria—Celebrating 100 Years of Pathophysiology in Bulgaria". Cureus: 2. doi:10.7759/cureus.2404. PMID 29872585.
4. ↑ 4.0 4.1 4.2 4.3 Churilov, L. P. (December 2015). "From Physiology of Disease to Systemic Pathobiology: History and Current Trends in Pathophysiology.". Psychiatria Danubina 27 Suppl 2: 550–570. PMID 26657983. https://www.psychiatria-danubina.com/UserDocsImages/pdf/dnb_vol27_sup2/dnb_vol27_sup2_550.pdf.
5. ↑ Théodoridès J (1966). "Casimir Davaine (1812-1882): A precursor of Pasteur". Medical History 10 (2): 155–65. doi:10.1017/S0025727300010942. PMID 5325873.
6. ↑ 6.0 6.1 6.2 Bulloch, William, The History of Bacteriology (Oxford: Oxford University Press, 1938 & 1960 / New York: Dover Publications, 1979), p 143–144, 147-148
7. ↑ Carter KC (1980). "Germ theory, hysteria, and Freud's early work in psychopathology". Medical History 24 (3): 259–74. doi:10.1017/S002572730004031X. PMID 6997653.
8. ↑ 8.0 8.1 8.2 8.3 Silverman BD (2011). "William Henry Welch (1850-1934): The road to Johns Hopkins". Proceedings 24 (3): 236–42. doi:10.1080/08998280.2011.11928722. PMID 21738298.
9. ↑ Benson KR (1999). "Welch, Sedgwick, and the Hopkins model of hygiene". The Yale Journal of Biology and Medicine 72 (5): 313–20. PMID 11049162.
10. ↑ "In the bacteriology of the 1920s, the conversion of the R to the S form could be regarded as an adaptation to the environment. However, the transformation of Type I to Type II was the equivalent of the transformation of one species into another, a phenomenon never before observed. Avery was initially skeptical of Griffith's findings and, for some time, refused to accept the validity of his claims, believing that they were the result of inadequate experimental controls. Avery's research on therapeutic sera led him to conclude that pneumococcal types were fixed and that specific therapeutic agents could thus be developed to combat the various types. A transformation from type to type in vivo presented a disturbing clinical picture, as well as a challenge to the theoretical formulations of contemporary bacteriology" [Oswald T Avery Collection, "Shifting focus: Early work on bacterial transformation, 1928-1940", Profiles in Science, US National Library of Medicine, Web: 24 Jan 2013].
11. ↑ Dubos, René J, Oswald T Avery: His Life and Scientific Achievements (New York: Rockefeller University Press, 1976), pp 133, 135-136
12. ↑ 12.0 12.1 Dubos, René, "Memories of working in Oswald Avery's laboratory", Symposium Celebrating the Thirty-Fifth Anniversary of the Publication of "Studies on the chemical nature of the substance inducing transformation of pneumococcal types", 2 Feb 1979
13. ↑ Lederberg J (1956). "Notes on the biological interpretation of Fred Griffith's finding". American Scientist 44 (3): 268–269. http://profiles.nlm.nih.gov/ps/retrieve/ResourceMetadata/CCAAQX.
14. ↑ Lacks SA (Jan 2003). "Rambling and scrambling in bacterial transformation—a historical and personal memoir". J Bacteriol 185 (1): 1–6. doi:10.1128/jb.185.1.1-6.2003. PMID 12486033.
15. ↑ 15.0 15.1 15.2 15.3 15.4 Bechtel, William, Discovering Cell Mechanisms: The Creation of Modern Cell Biology (New York: Cambridge University Press, 2005)
16. ↑ Kay, Lily, Molecular Vision of Life: Caltech, the Rockefeller Foundation, and the Rise of the New Biology (New York: Oxford University Press, 1993)
17. ↑ 17.0 17.1 Institute of Medicine Forum on Microbial Threats (2009). "The Life and Legacies of Joshua Lederberg". Microbial Evolution and Co-Adaptation: A Tribute to the Life and Scientific Legacies of Joshua Lederberg: Workshop Summary. Washington DC: National Academies Press. ISBN 978-0-309-13121-6. https://www.ncbi.nlm.nih.gov/books/NBK45705/.
18. ↑ "Lewis Thomas and droopy rabbit ears". Journal of Experimental Medicine 204 (12): 2777. 2007. doi:10.1084/jem.20412fta.
19. ↑ Letter: Lewis Thomas (MSKCC) to Joshua Lederberg (Stanford Univ), 7 Aug 1978, p 1
20. ↑ Weissmann G (2006). "Planning science (a generation after Lewis Thomas)". Journal of Clinical Investigation 116 (6): 1463. doi:10.1172/JCI28895. PMID 16648878.
21. ↑ Tansey M. G., Goldberg M. S. (2010). "Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention". Neurobiology of Disease 37 (3): 510–518. doi:10.1016/j.nbd.2009.11.004. PMID 19913097.
22. ↑ Golan, Daniel; Staun-Ram, Elsebeth; Miller, Ariel (2016). "Shifting paradigms in multiple sclerosis". Current Opinion in Neurology 29 (3): 354–361. doi:10.1097/WCO.0000000000000324. PMID 27070218.
23. ↑ "Essential hypertension. Part I: definition and etiology". Circulation 101 (3): 329–35. January 2000. doi:10.1161/01.CIR.101.3.329. PMID 10645931.
24. ↑ "Pathogenesis of hypertension". Ann. Intern. Med. 139 (9): 761–76. November 2003. doi:10.7326/0003-4819-139-9-200311040-00011. PMID 14597461.
25. ↑ Hall, John E.; Guyton, Arthur C. (2006). Textbook of medical physiology. St. Louis, Mo: Elsevier Saunders. p. 228. ISBN 0-7216-0240-1. https://archive.org/details/textbookmedicalp00acgu.
26. ↑ "Hypertension: eMedicine Nephrology". http://emedicine.medscape.com/article/241381-overview.
27. ↑ Doitsh, G; Greene, WC (2016). "Dissecting How CD4 T Cells Are Lost During HIV Infection". Cell Host Microbe 19 (3): 280–91. doi:10.1016/j.chom.2016.02.012. PMID 26962940.
28. ↑ Flier JS (2004). "Obesity wars: Molecular progress confronts an expanding epidemic". Cell 116 (2): 337–50. doi:10.1016/S0092-8674(03)01081-X. PMID 14744442.
29. ↑ Rodriguez-Muñoz, A.; Motahari-Rad, H.; Martin-Chaves, L.; Benitez-Porres, J.; Rodriguez-Capitan, J.; Gonzalez-Jimenez, A.; Insenser, M.; Tinahones, F.J. et al. (2024). "A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle". Current Obesity Reports 13 (3): 403–438. doi:10.1007/s13679-024-00561-4. PMID 38703299.
30. ↑ Zhang, Y; Proenca, R; Maffei, M; Barone, M; Leopold, L; Friedman, JM (Dec 1, 1994). "Positional cloning of the mouse obese gene and its human homologue.". Nature 372 (6505): 425–32. doi:10.1038/372425a0. PMID 7984236. Bibcode: 1994Natur.372..425Z.
31. ↑ Considine, RV; Considine, EL; Williams, CJ; Nyce, MR; Magosin, SA; Bauer, TL; Rosato, EL; Colberg, J et al. (Jun 1995). "Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity.". The Journal of Clinical Investigation 95 (6): 2986–8. doi:10.1172/jci118007. PMID 7769141.

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Pathophysiology. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Medicine:Pathophysiology&oldid=4070351"